Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn2+ on bacteriolytic activity

Protein Expr Purif. 2018 Nov:151:106-112. doi: 10.1016/j.pep.2018.06.013. Epub 2018 Jun 23.

Abstract

Lysostaphin, a bacteriolytic toxin from Staphylococcus simulans, is a Zn2+-dependent endopeptidase that cleaves pentaglycine cross-bridges found in peptidoglycan of certain Staphylococci. Here, we have investigated a critical influence of Zn2+ ions on lysostaphin-induced bioactivity. Initially, we succeeded in producing a large amount with high purity of the 28-kDa His-tagged mature lysostaphin via soluble expression in Escherichia coli and subsequent purification via immobilized-Ni2+ affinity chromatography (IMAC). The purified monomeric bacteriocin exhibited concentration-dependent bioactivity against S. aureus and its methicillin-resistant strain through cell-wall hydrolysis rather than membrane perturbation. Following pre-incubation of the purified lysostaphin with exogenous Zn2+, a marked inhibition in staphylolytic activity was observed. When the pre-mixture was exposed to 1,10-phenanthroline (PNT, a Zn2+-chelator), the adverse effect of the exogenous Zn2+ on bioactivity was greatly decreased. Conversely, lysostaphin pre-treated with excess PNT retained relatively high bioactivity, indicating ineffective chelation of PNT to detach the catalytic Zn2+ from the active-site pocket. Structural analysis of the lysostaphin-catalytic domain together with amino acid sequence alignments of lysostaphin-like endopeptidases revealed a potential extraneous Zn2+-binding site found in close proximity to the Zn2+-coordinating active site. Overall our results provide more insights into an adverse influence of exogenous Zn2+ ions on staphylolytic activity of the purified Zn2+-dependent endopeptidase lysostaphin, implicating the presence of an extraneous inhibitory metal-binding site.

Keywords: Bacteriocin lysostaphin; Inhibitory metal-binding site; Staphylolytic activity; Zn(2+) chelation; Zn(2+)-dependent endopeptidase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / biosynthesis
  • Anti-Bacterial Agents / isolation & purification*
  • Anti-Bacterial Agents / pharmacology
  • Biocatalysis
  • Cations, Divalent
  • Cell Wall / metabolism
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacology
  • Coordination Complexes / chemistry
  • Coordination Complexes / pharmacology
  • Drug Resistance, Bacterial
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Lysostaphin / biosynthesis
  • Lysostaphin / isolation & purification*
  • Lysostaphin / pharmacology
  • Phenanthrolines / chemistry
  • Phenanthrolines / pharmacology
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / pharmacology
  • Staphylococcus / enzymology*
  • Staphylococcus aureus / drug effects
  • Zinc / chemistry
  • Zinc / pharmacology

Substances

  • Anti-Bacterial Agents
  • Cations, Divalent
  • Chelating Agents
  • Coordination Complexes
  • Phenanthrolines
  • Recombinant Proteins
  • Lysostaphin
  • Zinc
  • 1,10-phenanthroline